Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867578 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03867578: Completed NA study, sponsored by University of Chicago.
NCT03867578 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03867578, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these cancers. Researchers will use new MRI and ultrasound techniques to see if it can find evidence of cancer that has spread to the lining of the abdomen, and right now these new techniques are only used for research.
Primary Outcome
New HR-MRI sequences will demonstrate greater sensitivity than standard MRI for detecting peritoneal metastases.
Interventions
- DIAGNOSTIC_TEST Ultrasound
- DIAGNOSTIC_TEST HR-MRI
- DIAGNOSTIC_TEST Standard CT Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2022-07-20 |
| Phase | NA |
What the finished NCT03867578 record still lists
NCT03867578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Ultrasound is the first listed.
NCT03867578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03867578 about?
NCT03867578 is a clinical study titled "Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma". For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these cancers...
What is the current status of trial NCT03867578?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-10-10. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT03867578?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST), HR-MRI (DIAGNOSTIC_TEST), Standard CT Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03867578?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03867578's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI